Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213505718> ?p ?o ?g. }
- W3213505718 endingPage "2415" @default.
- W3213505718 startingPage "2407" @default.
- W3213505718 abstract "Abstract Background Quality of life in cancer patients might be affected by chemotherapy-induced toxicity. Especially in patients with pancreatic ductal adenocarcinoma (PDAC), with a short life expectancy, fear of poor quality of life is often a reason for both patients and medical oncologists to refrain from further treatment. In this study, we investigated quality of life (QoL), pain, sleep, and activity levels in locally advanced pancreatic cancer (LAPC) patients after FOLFIRINOX treatment. Methods A total of 41 LAPC patients with stable disease or partial response were included after completion of at least four cycles of FOLFIRINOX. QoL was measured with the EORTC QLQ-C30 and NRS pain scores. Patients completed the Richards-Campbell Sleep Questionnaire (RCSQ) for five consecutive nights and wore a GENEActiv tri-axial accelerometer (Actiwatch) for 7 days, registering sleep duration, efficiency, and activity. Results Mean EORTC QLQ-C30 score for global health status was 78.3 (± 17.3), higher than reference values for cancer patients ( P < 0.001) and general population ( P = 0.045). LAPC patients reported few disease-related symptoms. Two patients (5%) reported pain scores > 3. Mean sleep duration was 8 h/night (± 1.2 h) and sleep efficiency 70% (± 9%) with high patient-reported quality of sleep (mean RCSQ score 72.0 ± 11.4). Mean duration of moderate-vigorous activity was 37 min/week (± 103 min/week). Conclusions QoL is very good in most LAPC patients with disease control after FOLFIRINOX, measured with validated questionnaires and Actiwatch registration. The fear of clinical deterioration after FOLFIRINOX is not substantiated by this study and should not be a reason to refrain from treatment. Trial registration Dutch trial register NL7578." @default.
- W3213505718 created "2021-11-22" @default.
- W3213505718 creator A5004273348 @default.
- W3213505718 creator A5006641161 @default.
- W3213505718 creator A5011747853 @default.
- W3213505718 creator A5012050627 @default.
- W3213505718 creator A5054427267 @default.
- W3213505718 creator A5087356156 @default.
- W3213505718 creator A5087646037 @default.
- W3213505718 date "2021-11-11" @default.
- W3213505718 modified "2023-10-14" @default.
- W3213505718 title "Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment" @default.
- W3213505718 cites W1563878414 @default.
- W3213505718 cites W2042799375 @default.
- W3213505718 cites W2088735383 @default.
- W3213505718 cites W2090481758 @default.
- W3213505718 cites W2115827170 @default.
- W3213505718 cites W2128638328 @default.
- W3213505718 cites W2128889451 @default.
- W3213505718 cites W2137027807 @default.
- W3213505718 cites W2156408397 @default.
- W3213505718 cites W2167571044 @default.
- W3213505718 cites W2168645047 @default.
- W3213505718 cites W2178029327 @default.
- W3213505718 cites W2345822778 @default.
- W3213505718 cites W2467479187 @default.
- W3213505718 cites W2520774580 @default.
- W3213505718 cites W2566124428 @default.
- W3213505718 cites W2647780868 @default.
- W3213505718 cites W2762068536 @default.
- W3213505718 cites W2782140564 @default.
- W3213505718 cites W2801551214 @default.
- W3213505718 cites W2807847564 @default.
- W3213505718 cites W2954226707 @default.
- W3213505718 cites W2989786100 @default.
- W3213505718 cites W2994361394 @default.
- W3213505718 cites W3033675765 @default.
- W3213505718 cites W3108106255 @default.
- W3213505718 doi "https://doi.org/10.1007/s00520-021-06648-1" @default.
- W3213505718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34762217" @default.
- W3213505718 hasPublicationYear "2021" @default.
- W3213505718 type Work @default.
- W3213505718 sameAs 3213505718 @default.
- W3213505718 citedByCount "2" @default.
- W3213505718 countsByYear W32135057182022 @default.
- W3213505718 countsByYear W32135057182023 @default.
- W3213505718 crossrefType "journal-article" @default.
- W3213505718 hasAuthorship W3213505718A5004273348 @default.
- W3213505718 hasAuthorship W3213505718A5006641161 @default.
- W3213505718 hasAuthorship W3213505718A5011747853 @default.
- W3213505718 hasAuthorship W3213505718A5012050627 @default.
- W3213505718 hasAuthorship W3213505718A5054427267 @default.
- W3213505718 hasAuthorship W3213505718A5087356156 @default.
- W3213505718 hasAuthorship W3213505718A5087646037 @default.
- W3213505718 hasBestOaLocation W32135057181 @default.
- W3213505718 hasConcept C121608353 @default.
- W3213505718 hasConcept C126322002 @default.
- W3213505718 hasConcept C143998085 @default.
- W3213505718 hasConcept C159110408 @default.
- W3213505718 hasConcept C1862650 @default.
- W3213505718 hasConcept C2776907518 @default.
- W3213505718 hasConcept C2777148230 @default.
- W3213505718 hasConcept C2779526319 @default.
- W3213505718 hasConcept C2779951463 @default.
- W3213505718 hasConcept C2780210213 @default.
- W3213505718 hasConcept C2780962732 @default.
- W3213505718 hasConcept C2908647359 @default.
- W3213505718 hasConcept C2991975920 @default.
- W3213505718 hasConcept C2994186709 @default.
- W3213505718 hasConcept C42219234 @default.
- W3213505718 hasConcept C526805850 @default.
- W3213505718 hasConcept C71924100 @default.
- W3213505718 hasConcept C99454951 @default.
- W3213505718 hasConceptScore W3213505718C121608353 @default.
- W3213505718 hasConceptScore W3213505718C126322002 @default.
- W3213505718 hasConceptScore W3213505718C143998085 @default.
- W3213505718 hasConceptScore W3213505718C159110408 @default.
- W3213505718 hasConceptScore W3213505718C1862650 @default.
- W3213505718 hasConceptScore W3213505718C2776907518 @default.
- W3213505718 hasConceptScore W3213505718C2777148230 @default.
- W3213505718 hasConceptScore W3213505718C2779526319 @default.
- W3213505718 hasConceptScore W3213505718C2779951463 @default.
- W3213505718 hasConceptScore W3213505718C2780210213 @default.
- W3213505718 hasConceptScore W3213505718C2780962732 @default.
- W3213505718 hasConceptScore W3213505718C2908647359 @default.
- W3213505718 hasConceptScore W3213505718C2991975920 @default.
- W3213505718 hasConceptScore W3213505718C2994186709 @default.
- W3213505718 hasConceptScore W3213505718C42219234 @default.
- W3213505718 hasConceptScore W3213505718C526805850 @default.
- W3213505718 hasConceptScore W3213505718C71924100 @default.
- W3213505718 hasConceptScore W3213505718C99454951 @default.
- W3213505718 hasIssue "3" @default.
- W3213505718 hasLocation W32135057181 @default.
- W3213505718 hasLocation W32135057182 @default.
- W3213505718 hasLocation W32135057183 @default.
- W3213505718 hasLocation W32135057184 @default.
- W3213505718 hasLocation W32135057185 @default.
- W3213505718 hasOpenAccess W3213505718 @default.